The occurrence and development of digestive tract tumors are mainly caused by the interaction of genetic and environmental factors, multiple incentives, multiple genes involved, and multi-step regulation. With the development of gene sequencing technology, precise treatment of tumor era has arrived . Studies have shown that the HOXA13 gene in the homeobox gene is abnormally expressed in digestive system tumors. Studies have shown that HOXA13 may have a certain relationship with the occurrence, development and prognosis of the tumor, pending the diagnosis and treatment of digestive tract tumors with a new gene target.
KeywordsHOXA13HOTTIPTumor of Digestive Tract
Yang, X.P., Liu, W.W., et al. (2015) Epidemiological Investigation of 1108 Patients with Esophageal Cancer. Chinese Journal of Gastrointestinal Endoscopy, 2, 118-121.
He, J. and Shao, K. (2011) Epidemiological Status, Diagnosis and Treatment of Esophageal Cancer in China and Its Future Strategy. Chinese Journal of Cancer, 21, 501-503.
Fitzgerald, R.C., Di Pietro, M., Ragunath, K., et al. (2014) British Society of Gastroentery Guidelines on the Diagnosis and Management of Barrett’s Oesophagus. Gut, 63, 7-42. https://doi.org/10.1136/gutjnl-2013-305372
Zuo, T.T., Zheng, R.S., Zeng, H.M., et al. (2017) Epidemiological Status of Gastric Cancer in China. Chinese Cancer Clinic, 44, 52-58.
Lu, Y.F., Liu, Z.C., Li, Z.H., et al. (2014) Esophageal/Gastric Cancer Screening in High-Risk Populations in Henan Province, China. Asian Pacific Journal of Cancer Prevention, 15, 1419-1422. https://doi.org/10.7314/APJCP.2014.15.3.1419
Yamamoto, K., Tsujinaka, T., Takahashi, T., et al. (2015) Impact of the Japanese Gastric Cancer Screening System on Treatment Outcomes in Gastric Gastrointestinal Stromal Tumor (GIST): An Analysis Based on the GIST Registry. Annals of Surgical Oncology, 22, 232-239. https://doi.org/10.1245/s10434-014-3971-4
Xiang, S., Liang, D.K., et al. (2016) Progress in the Research and Treatment of Pancreatic Cancer in China. Chinese Journal of Cancer, 26, 281-289.
Ma, S.J., Qu, Z.L., Hole, D., et al. (2015) Progress of Pancreatic Cancer Diagnosis and Epidemiological Research. Chinese Combining Traditional Chinese and Western Medicine. Journal of Surgery, 21, 87-92.
Siegel, R., Naishadham, D. and Jemal, A. (2013) Cancer Statistics, 2013. CA: A Cancer Journal for Clinicians, 63, 11-30. https://doi.org/10.3322/caac.21166
StatBite. (2010) U.S. Pancreatic Cancer Rates. Journal of the National Cancer Institute, 102, 18-22.
Ma, C. and Jiang, Y.X. (2013) Trend and Prediction on the Incidence of Pancreatic Cancer in China. Chinese Journal of Epidemiology, 34, 160-163.
Lv, G.S., Chen, L., Wang, H.Y., et al. (2015) The Current Situation and Prospect of Liver Cancer Research in China. Life Sciences, 27, 237-248.
Wang, F.S., Fan, J.G., Zhang, Z., Gao, B. and Wang, H.Y. (2014) The Global Burden of Liver Disease: The Major Impact of China. Hepatology, 60, 2099-2108. https://doi.org/10.1002/hep.27406
Nie, L.H., Mei, C., Wen, J., et al. (2004) Regulation of Homeobox Genes on Vascular Smooth Muscle Cells. Cell Biology Journal, 26, 352-356.
Song, Z. (2003) Homeobox Gene and Tumor. Foreign Medical Oncology Section, 30, 163-166.
Xia, H. (2007) Hox Gene and Tumor Progression Research. International Journal of Stomatology, 34, 412-414.
Yan, J., Dang, Y., Liu, S.Y., et al. (2016) LncRNA HOTAIR Promotes Cisplatin Resistance in Gastric Cancer by Targeting miR-126 to Activate the PI3K/AKT/MRP1 Genes.
Kyung, J.M., Jong-Jae, P. and Chun, H.J. (2016) Impact of Homeobox Genes in Gastrointestinal Cancer. World Journal of Gastroenterology, 22, 8247-8256. https://doi.org/10.3748/wjg.v22.i37.8247
Goodman, F.R. and Scambler, P.J. (2001) Human HOX Gene Mutations. Clinical Genetics, 59, 1-11. https://doi.org/10.1034/j.1399-0004.2001.590101.x
Grier, D.G., Thompson, A., Kwasniewska, A., et al. (2005) The Pathophysiology of HOX Genes and Their Role in Cancer. The Journal of Pathology, 205, 154-171. https://doi.org/10.1002/path.1710
Naora Honami, S.S. (2005) Homeobox Gene Expression in Cancer: Insights from Developmental Regulation and Deregulation. European Journal of Cancer, 41, 2428-2437. https://doi.org/10.1016/j.ejca.2005.08.014
Bhatlekar, S. and Fields, J.Z. (2014) Bomanbruce MHOX Genes and Their Role in the Development of Human Cancers. Journal of Molecular Medicine, 92, 811-823. https://doi.org/10.1007/s00109-014-1181-y
Sukumar Saraswati, N.S. (2010) The Hox Genes and Their Roles in Oncogenesis. Nature Reviews Cancer, 10, 361-371. https://doi.org/10.1038/nrc2826
Who, C.S. (2011) Russell Steven Genomic Approaches to Understanding Hox Gene Function. Advances in Genetics, 76, 55-91. https://doi.org/10.1016/B978-0-12-386481-9.00003-1
Wang, S.S., Wuputra, K., Liu, C.J., et al. (2016) Oncogenic Function of the Homeobox A13-Long Noncoding RNA HOTTIP-Insulin Growth Factor-Binding Protein 3 Axis in Human Gastric Cancer. Oncotarget, 7, 36049-36064. https://doi.org/10.18632/oncotarget.9102
Chang, S., Liu, J.S., Guo, S.C., et al. (2016) HOTTIP and HOXA13 Are Oncogenes Associated with Gastric Cancer Progression. Oncology Reports, 35, 3577-3585. https://doi.org/10.3892/or.2016.4743
Lian, Y.F., Cai, Z.L., Gong, H.B., et al. (2016) HOTTIP: A Critical Oncogenic Long Non-Coding RNA in Human Cancers.
Quagliata, L., Matter, M.S., Piscuoglio, S.A., et al. (2014) Long Noncoding RNA HOTTIP/HOXA13 Expression Is Associated with Disease Progression and Predicts Outcome in Hepatocellular Carcinoma Patients. Hepatology, 59, 911-923. https://doi.org/10.1002/hep.26740
Li, Z.H., Zhao, X.H., Zhou, Y., et al. (2015) The Long Non-Coding RNA HOTTIP Promotes Progression and Gemcitabine Resistance by Regulating HOXA13 in Pancreatic Cancer. Journal of Translational Medicine, 13, 442-444. https://doi.org/10.1186/s12967-015-0442-z
Duan, R., Han, L., Wang, Q.X., et al. (2015) HOXA13 Is a Potential GBM Diagnostic Marker and Promotes Glioma Invasion by Activating the Wnt and TGF-Beta Pathways. Oncotarget, 6, 27778-27793. https://doi.org/10.18632/oncotarget.4813
Qu, L.P., Zhong, Y.M., Zheng, Z., et al. (2017) CDH17 Is a Downstream Effector of HOXA13 in Modulating the Wnt/β-Catenin Signaling Pathway in Gastric Cancer. European Review for Medical and Pharmacological Sciences, 21, 1234-1241.
Bartolome, R.A., Barderas, R., Torres, S., et al. (2014) Cadherin-17 Interacts with Alpha 2 Beta 1 Integrin to Regulate Cell Proliferation and Adhesion in Colorectal Cancer Cells Causing Liver Metastasis. Oncogene, 33, 1658-1669. https://doi.org/10.1038/onc.2013.117
Qiu, H.B., Zhang, L.Y., Ren, C., Zeng, Z.L., Wu, W.J., Luo, H.Y., Zhou, Z.W. and Xu, R.H. (2013) Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/Beta-Catenin Signaling. PLoS ONE, 8, e56959. https://doi.org/10.1371/journal.pone.0056959
Li, R., Yang, H.Q., Xi, H.L., et al. (2017) Inhibition of CDH17 Gene Expression via RNA Interference Reduces Proliferation and Apoptosis of Human MKN28 Gastric Cancer Cells. International Journal of Oncology, 50, 15-22. https://doi.org/10.3892/ijo.2016.3783
Yan, W., Shen, L., Gu, Z., et al. (2009) Expression of Embryonic Gene HOXA13 in Esophageal Squamous Cell Carcinoma and Its Effect on the Prognosis of. The Chinese Journal of Gastrointestinal Surgery, 12, 20-23.
Shen, L.Y. and Chen, K.N. (2011) Exploration of Target Genes of HOXA13 in Esophageal Squamous Cell Carcinoma Cell Line. Cancer Letters, 312, 18-23. https://doi.org/10.1016/j.canlet.2011.07.020
Ma, R.L., Shen, L.Y. and Chen, K.-N. (2014) Coexpression of ANXA2, SOD2 and HOXA13 Predicts Poor Prognosis of Esophageal Squamous Cell Carcinoma. Oncology Reports, 31, 2157-2164. https://doi.org/10.3892/or.2014.3088
Han, Y., Tu, W.W., Wen, Y.G., et al. (2013) Identification and Validation That Up-Expression of HOXA13 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Based on Immunohistochemistry. Medical Oncology, 30, 564-566. https://doi.org/10.1007/s12032-013-0564-1
Du, M.L., Wang, W.Z., Jin, H., et al. (2015) The Association Analysis of lncRNA HOTAIR Genetic Variants and Gastric Cancer Risk in a Chinese Population. Oncotarget, 6, 31255-31262. https://doi.org/10.18632/oncotarget.5158
Yuan, C., Wang, S.W., Chen, W.I., et al. (2009) A Tumorigenic Homeobox(HOX)gene Expressing Human Gastric Cell Line Derived from Putative Gastric Stem Cell. European Journal of Gastroenterology & Hepatology, 21, 1016-1023. https://doi.org/10.1097/MEG.0b013e32831d7b9c
Pan, W., Liu, L., Wei, J., et al. (2016) A Functional lncRNA HOTAIR Genetic Variant Contributes to Gastric Cancer Susceptibility. Molecular Carcinogenesis, 55, 90-96. https://doi.org/10.1002/mc.22261
Bayram, S., Yakup, ü., Taner, S.A., et al. (2015) A Functional HOTAIR rs920778 Polymorphism Does Not Contributes to Gastric Cancer in a Turkish Population: A Case-Control Study. Familial Cancer, 14, 561-567. https://doi.org/10.1007/s10689-015-9813-0
Zhang, S.R., Yang, J.K., Xie, J.K., et al. (2016) Long Noncoding RNA HOTTIP Contributes to the Progression of Prostate Cancer by Regulating HOXA13. Cellular and Molecular Biology, 62, 84-88.
Kelly, Z., Moller-Levet, C., Sophie, M., Simon, B., Kierzek Andrzej, M., Hardev, P., Morgan, R., Agnieszka, M. and Kavitha, M.T. (2016) The Prognostic Significance of Specific HOX Gene Expression Patterns in Ovarian Cancer. International Journal of Cancer, 139, 1608-1617.
Su, X., Drabkin, H., Clappier, E., Morgado, E., Busson, M., Romana, S., Soulier, J., Berger, R., Bernard, O.A. and Lavau, C. (2006) Transforming Potential of the T-Cell Acute Lymphoblastic Leukemia-Associated Homeobox Genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer, 45, 846-855. https://doi.org/10.1002/gcc.20348